| Cynthia A George-michalik, PA-C | |
|
2001 S Wiesbrook Rd, Wheaton, IL 60189 | |
| (630) 614-4000 | |
| (630) 614-4048 |
| Full Name | Cynthia A George-michalik |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 31 Years |
| Location | 2001 S Wiesbrook Rd, Wheaton, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295886356 | NPI | - | NPPES |
| 211104 | Other | IL | MEDICARE PTAN (GROUP) |
| 592050 | Other | IL | MEDICARE PTAN (GROUP) |
| 592050002 | Other | IL | MEDICARE PTAN (INDIVIDUAL) |
| K15256 | Other | IL | MEDICARE PTAN (INDIVIDUAL) |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 085000582 (Illinois) | Secondary |
| 363A00000X | Physician Assistant | 085000582 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Dupage Hospital | Winfield, IL | Hospital |
| Delnor Community Hospital | Geneva, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Dupage Physician Group | 5890696231 | 1003 |
News Archive
The Washington Post: "Federal health officials Wednesday unveiled plans to replace the warnings cigarette packs began carrying 25 years ago with new versions using images that could include emaciated cancer patients, diseased organs and corpses. Public health authorities and anti-smoking advocates hailed the move as a milestone in the battle against tobacco in the United States that began in 1964 when the surgeon general first declared cigarettes a public health threat.
Research from Mayo Clinic included in the November issue of JAMA Neurology identifies a new biomarker for brain and spinal cord inflammation, allowing for faster diagnosis and treatment of patients.
The American Academy of Dermatology's 70th Annual Meeting, recently held in San Diego from March 16-20, had a record attendance of more than 19,300 people from more than 102 countries.
Pharmacyclics, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for the investigational oral Bruton's tyrosine kinase inhibitor, ibrutinib, for two relapsed/refractory B-cell malignancy indications: mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia A George-michalik, PA-C 2001 S Wiesbrook Rd, Wheaton, IL 60189-7813 Ph: (630) 614-4000 | Cynthia A George-michalik, PA-C 2001 S Wiesbrook Rd, Wheaton, IL 60189 Ph: (630) 614-4000 |
News Archive
The Washington Post: "Federal health officials Wednesday unveiled plans to replace the warnings cigarette packs began carrying 25 years ago with new versions using images that could include emaciated cancer patients, diseased organs and corpses. Public health authorities and anti-smoking advocates hailed the move as a milestone in the battle against tobacco in the United States that began in 1964 when the surgeon general first declared cigarettes a public health threat.
Research from Mayo Clinic included in the November issue of JAMA Neurology identifies a new biomarker for brain and spinal cord inflammation, allowing for faster diagnosis and treatment of patients.
The American Academy of Dermatology's 70th Annual Meeting, recently held in San Diego from March 16-20, had a record attendance of more than 19,300 people from more than 102 countries.
Pharmacyclics, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for the investigational oral Bruton's tyrosine kinase inhibitor, ibrutinib, for two relapsed/refractory B-cell malignancy indications: mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.
› Verified 5 days ago